ArticleMolecular cancer therapeutics2025

18F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors.

Anand Giddabasappa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.